Downloads: 172 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper | Biology | India | Volume 9 Issue 7, July 2020
Hydroxychloroquine for COVID-19: A Review
Abstract: In dealing with the COVID-19 pandemic, hydroxychloroquine (HCQ) as a drug captured serious worldwide attention. Some in-vitro and in-vivo studies recently showing possible inhibition of SARS-CoV-2 by the use of HCQ. At same time, however, a few cases research demonstrating NO medical benefit/ poor clinical result with major adverse effects through the use of HCQ in coronavirus disease-2019 treatment. Therefore, the use of HCQ (in treatment with COVID-19) is of considerable international concern, although a consensus has not yet been reached. Further proof to prove HCQ 's efficacy against COVID-19 is still needed. In view of this, the current analysis illustrates the ongoing work on use of HCQ in the management of coronavirus disease-2019. The present analysis will address the potential in-vitro study of HCQ's anti-viral function, prophylaxis strategy and impact of HCQ on SARS-CoV-2 viruses. This review also sums up and discusses all clinical practice trials / HCQ use research studies against COVID-19 (with clinical results). Finally, considering the public health and pharmacovigilance concerns, possible detrimental effects are also discussed.
Keywords: hydroxychloroquine, COVID-19, Coronavirus disease-2019, Clinical trials, SARS-CoV-2, adverse effects of hydroxychloroquine, Pharmacovigilance concern
Edition: Volume 9 Issue 7, July 2020,
Pages: 1345 - 1348
Similar Articles with Keyword 'Clinical trials'
Sodium Nitrite Induced Biochemical Alterations in the Blood Serum and its Amelioration by Aqueous Extract of Libyan Propolis in Guinea Pigs
Mammalian Expression System and Improvisation for High Production
Bindu Kodati | Sailaja Darbha